By modifying and boosting lab equipment, a team of chemists are able to measure individual molecules with unprecedented precision. Their massive resolution upgrading will benefit the fabrication of vaccines and molecular vectors used in gene therapy.
Many cancer drugs recently approved by the European Medicines Agency (EMA) lack clear proof of added benefit. This is particularly the case for drugs that are granted via special processes, intended to accelerate the approval of promising treatments.